MARKET

GCTK

GCTK

Glucotrack
NASDAQ
0.2862
-0.0349
-10.87%
After Hours: 0.2892 +0.003 +1.05% 19:59 08/27 EDT
OPEN
0.3348
PREV CLOSE
0.3211
HIGH
0.3348
LOW
0.2825
VOLUME
1.69M
TURNOVER
--
52 WEEK HIGH
14.14
52 WEEK LOW
0.2500
MARKET CAP
3.03M
P/E (TTM)
-0.0137
1D
5D
1M
3M
1Y
5Y
1D
GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100
TipRanks · 2d ago
Glucotrack's Lōkahi Therapeutic Subsidiary Initiates Good Manufacturing Practice Production Campaign For LT-100
Benzinga · 2d ago
Weekly Report: what happened at GCTK last week (0817-0821)?
Weekly Report · 3d ago
Lokahi expands ai2 Future Labs asset origination netowrk
TipRanks · 6d ago
GlucoTrack Shareholders Approve Key Governance and Capital Actions
TipRanks · 08/19 13:27
GlucoTrack achieves key compliance milestone
TipRanks · 08/17 12:11
Glucotrack Announces That Nasdaq Hearings Panel Has Granted The Company's Request For Continued Listing, Subject To Conditions
Benzinga · 08/17 12:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 08/17 12:06
More
About GCTK
Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.

Webull offers GlucoTrack Inc stock information, including NASDAQ: GCTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCTK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GCTK stock methods without spending real money on the virtual paper trading platform.